Carol Vorwerck v. HHS - Pneumococcal, eosinophilic granulomatosis with polyangiitis (2023)

Carol Vorwerck filed a petition on May 29, 2018, alleging that she suffered from eosinophilic granulomatosis with polyangiitis (EGPA) as a result of a pneumococcal vaccine (Prevnar) she received on October 7, 2016. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Petitioner's alleged EGPA or any other injury, and denied that her current disabilities were a sequela of a vaccine-related injury.

Despite the respondent's denial, the parties reached a stipulation recommending an award of compensation, which was filed on May 16, 2023. Special Master Nora Beth Dorsey adopted the stipulation as the decision of the Court.

Under the terms of the stipulation, Carol Vorwerck was awarded a lump sum of $50,000.00 as compensation for all damages available under the National Vaccine Injury Compensation Program. The parties agreed to waive their right to seek review, and judgment was entered accordingly.

The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses. Petitioner was represented by Diana Lynn Stadelnikas of Maglio Christopher and Toale, PA, and Respondent was represented by Colleen Clemons Hartley of the U.S.

Department of Justice.